- Home
- ITIC vs OLMA Comparison
ITIC vs OLMA Comparison
Compare ITIC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITIC
- OLMA
- Stock Information
- Founded
- ITIC 1972
- OLMA 2006
- Country
- ITIC United States
- OLMA United States
- Employees
- ITIC N/A
- OLMA N/A
- Industry
- ITIC Specialty Insurers
- OLMA Biotechnology: Pharmaceutical Preparations
- Sector
- ITIC Finance
- OLMA Health Care
- Exchange
- ITIC Nasdaq
- OLMA Nasdaq
- Market Cap
- ITIC 423.0M
- OLMA 383.1M
- IPO Year
- ITIC N/A
- OLMA 2020
- Fundamental
- Price
- ITIC $224.28
- OLMA $4.99
- Analyst Decision
- ITIC
- OLMA Strong Buy
- Analyst Count
- ITIC 0
- OLMA 4
- Target Price
- ITIC N/A
- OLMA $28.33
- AVG Volume (30 Days)
- ITIC 10.1K
- OLMA 986.5K
- Earning Date
- ITIC 02-13-2025
- OLMA 03-10-2025
- Dividend Yield
- ITIC 6.90%
- OLMA N/A
- EPS Growth
- ITIC 43.49
- OLMA N/A
- EPS
- ITIC 16.43
- OLMA N/A
- Revenue
- ITIC $258,298,000.00
- OLMA N/A
- Revenue This Year
- ITIC N/A
- OLMA N/A
- Revenue Next Year
- ITIC N/A
- OLMA N/A
- P/E Ratio
- ITIC $14.11
- OLMA N/A
- Revenue Growth
- ITIC 15.03
- OLMA N/A
- 52 Week Low
- ITIC $146.41
- OLMA $4.60
- 52 Week High
- ITIC $290.40
- OLMA $16.62
- Technical
- Relative Strength Index (RSI)
- ITIC 44.36
- OLMA 38.98
- Support Level
- ITIC $220.01
- OLMA $4.94
- Resistance Level
- ITIC $233.74
- OLMA $5.34
- Average True Range (ATR)
- ITIC 5.38
- OLMA 0.42
- MACD
- ITIC 0.93
- OLMA -0.03
- Stochastic Oscillator
- ITIC 37.02
- OLMA 11.39
About ITIC Investors Title Company
Investors Title Co operates primarily in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment primarily issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.